New Rochelle, NY, December 2, 2013–The Genetics Policy Institute (GPI) will bestow its 2013 Education Award on Mary Ann Liebert, President and CEO of the company that bears her name, citing her work in educating patients, researchers, and the broader stem cell community, and in raising the standard in medical research journalism. Ms. Liebert is the president and CEO of Mary Ann Liebert, Inc., a media empire known for establishing authoritative peer-reviewed journals in promising areas of science and biomedical research. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), debuted in 1980, was the first in its field, and is today the industry’s most widely read publication worldwide. Stem Cells and Development is an authoritative peer-reviewed journal dedicated to developments in the biology, characteristics, and therapeutic utility of stem cells. Many journals she publishes intersect the field of regenerative medicine, contributing to the scholarship and advancing stem cell science. Ms. Liebert is also the founder and executive vice president of the Rosalind Franklin Society, which recognizes and advances important contributions made by women in the life sciences.
Recent Posts
- Socioeconomic Barriers Limit Access to Lifesaving Stem Cell Transplants in AML
- Newly discovered mechanism in the cell’s energy factory can lead to new treatment of muscle disorders
- New drug tested to reduce side effect of ‘half-matched’ stem cell transplants
- Gene and Cell Therapies Take Aim at Parkinson’s Disease
- Health Net grant for UC Davis Stem Cell Program to improve access to CAR T-cell therapy
- Stem cell therapy TED-A9 showing safety and early efficacy in trial